Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


ACC 2021: Key Studies Affecting Clinical Care of Heart Failure

Lee R. Goldberg, MD, MPH, FACC
James Udelson, MD
Released: July 28, 2021
Back Next


In this module, Lee R Goldberg, MD, MPH, and James Udelson MD, discuss key studies that will affect the management of patients with heart failure (HF), including new data on sodium-glucose cotransporter 2 (SGLT2) inhibition in HF, and treatments for HF with reduced ejection fraction and HF with preserved ejection fraction.

Back Next
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings